Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intractable pain with lung cancer.

Peter N Watson1, Ramon J Evans

  • 1Irene Eleanor Smythe Pain Clinic, University of Toronto, Toronto General Hospital, Toronto, Ont. M5G 2C4 Canada.

Pain
|May 1, 1987
PubMed
Summary

Intractable pain in lung cancer patients is often caused by skeletal metastases or Pancoast tumors. Treatments vary, with a median survival of 10 months after pain onset.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postherpetic neuralgia.

BMJ clinical evidence·2011
Same author

The postmastectomy pain syndrome and topical capsaicin: a randomized trial.

Pain·1992
Same author

Amitriptyline versus maprotiline in postherpetic neuralgia: a randomized, double-blind, crossover trial.

Pain·1992
Same author

The prognosis with postherpetic neuralgia.

Pain·1991
Same author

Post-herpetic neuralgia: 208 cases.

Pain·1988
Same author

Post-herpetic neuralgia and topical capsaicin.

Pain·1988

Area of Science:

  • Oncology
  • Pain Medicine
  • Palliative Care

Background:

  • Intractable pain is a significant challenge in lung cancer management.
  • Understanding the causes and outcomes of this pain is crucial for improving patient care.

Purpose of the Study:

  • To retrospectively analyze the natural history, classification, clinical and pathological features, and treatment outcomes of intractable pain in lung cancer patients.
  • To identify the primary causes of malignancy-related pain in this cohort.

Main Methods:

  • Retrospective review of 221 lung cancer patients with intractable pain.
  • Analysis of pain causes, time intervals, pathological types, treatment modalities, and survival data.

Main Results:

  • Skeletal metastatic disease (34%), Pancoast's tumour (31%), and chest wall disease (21%) were the main causes of pain, accounting for 78% of cases.
  • The median interval between cancer diagnosis and pain onset was 1 month.
  • Treatment modalities included radiation, percutaneous cordotomy, regional deafferentation, and pharmacotherapy.

Conclusions:

  • Pain in lung cancer is frequently linked to specific metastatic patterns and tumor locations.
  • A multidisciplinary approach to pain management is essential for lung cancer patients.
  • Further research into targeted pain interventions can improve survival and quality of life.

Related Experiment Videos